Blog
RSS FeedPosted by Michael Wonder on 07 Dec 2017
Roche’s Tecentriq available via CDF
7 December 2017 - Roche’s Tecentriq will be available on the NHS in England via the Cancer Drugs Fund for ...
Posted by Michael Wonder on 27 Nov 2017
Merck invited to submit a CDF proposal for Merkel cell cancer drug
27 November 2017 - NICE has asked Merck to submit a Cancer Drugs Fund proposal for an immunotherapy called avelumab. ...
Posted by Michael Wonder on 16 Oct 2017
Roche’s skin cancer drug Erivedge pulled from CDF
13 October 2017 - Roche’s Erivedge could be removed from the Cancer Drugs Fund within months after the National Institute ...
Posted by Michael Wonder on 10 Aug 2017
Patients getting faster access to cancer drugs as NICE approves three quarters of the Cancer Drugs Fund
10 August 2017 - Liver cancer drug, sorafenib has been approved for routine NHS use, marking three quarters of the way ...
Posted by Michael Wonder on 05 Jul 2017
Merck’s Keytruda, Lilly’s Lartruvo available via CDF
5 July 2017 - Patients with certain forms of lung cancer or sarcoma have now gained access to two new ...
Posted by Michael Wonder on 28 Jun 2017
Cancer Drugs Fund driving early access to promising new treatments
28 June 2017 - NHS patients in England are getting early access to new drugs for lung cancer and sarcoma, ...
Posted by Michael Wonder on 07 Jun 2017
Cancer Drugs Fund of minimal benefit
6 June 2017 - A new study has concluded that the medicines available in the previous version of the NHS Cancer ...
Posted by Michael Wonder on 01 Jun 2017
Britain backs first-line use of Merck's Keytruda under cancer fund
31 May 2017 - Britain's cost-effectiveness agency NICE has decided that Merck & Co's immunotherapy drug Keytruda can be used ...
Posted by Michael Wonder on 26 May 2017
Conservatism and the cancer drugs fund
24 May 2017 - Are some patients—and some people— more deserving than others? ...
Posted by Michael Wonder on 01 May 2017
Cancer fund failure highlights the dilemma of drug pricing
1 May 2017 - The challenge is to keep treatments affordable but still encourage innovation. ...
Posted by Michael Wonder on 29 Apr 2017
Cancer Drugs Fund condemned as expensive and ineffective
28 April 2017 - Treatments approved by David Cameron’s scheme were not worth money, extended life very little and often had ...
Posted by Michael Wonder on 29 Oct 2016
Cancer Drugs Fund: the bigger picture
26 October 2016 - Carole Longson and others from NICE welcome the authors’ creative ideas on the appraisal of cancer ...
Posted by Michael Wonder on 04 Oct 2016
NICE recommends new drug osimertinib for hundreds of people with lung cancer
4 October 2016 - Hundreds of people with lung cancer will now have access to new drug osimertinib, also known as ...
Posted by Michael Wonder on 29 Sep 2016
Cancer Drugs Fund requires further reform
27 September 2016 - Reliance on “real world” observational data undermines evidence base for clinical practice. ...
Posted by Michael Wonder on 24 Aug 2016
NICE approves new cancer drugs for routine NHS use
24 August 2016 - Two cancer treatments, previously only available to patients through the Cancer Drugs Fund, will now be routinely ...